Suppr超能文献

孕期抗糖尿病药物的使用:当前实践与争议

Use of antidiabetes agents in pregnancy: current practice and controversy.

作者信息

Slocum Julie M, Sosa Mary Ellen Burke

机构信息

Division of Maternal Fetal Medicine, Women & Infants' Hospital, and Brown University School of Medicine, Providence, Rhode Island, USA.

出版信息

J Perinat Neonatal Nurs. 2002 Sep;16(2):40-53; quiz 2 p following 84. doi: 10.1097/00005237-200209000-00005.

Abstract

Prior to the discovery of insulin, the combination of diabetes and pregnancy was considered potentially lethal. Advances in the care of diabetes, combined with advances in antepartum fetal testing, have reduced maternal and perinatal mortality outcomes to levels expected in nondiabetic pregnancies. As new oral antidiabetes medications are introduced, the safety and efficacy of using them during pregnancy are under investigation. This article describes the oral medications currently available to treat diabetes, reviews the body of research available on these agents, and discusses current recommendations and controversies.

摘要

在胰岛素被发现之前,糖尿病与妊娠并存被认为具有潜在致命性。糖尿病护理方面的进展,再加上产前胎儿检测技术的进步,已将孕产妇和围产期死亡率降低至非糖尿病妊娠所预期的水平。随着新型口服抗糖尿病药物的问世,其在孕期使用的安全性和有效性正在接受研究。本文介绍了目前可用于治疗糖尿病的口服药物,回顾了关于这些药物的现有研究,并讨论了当前的建议和争议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验